BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

873 related articles for article (PubMed ID: 18716065)

  • 1. Blockade of CXCL12/CXCR4 axis ameliorates murine experimental colitis.
    Mikami S; Nakase H; Yamamoto S; Takeda Y; Yoshino T; Kasahara K; Ueno S; Uza N; Oishi S; Fujii N; Nagasawa T; Chiba T
    J Pharmacol Exp Ther; 2008 Nov; 327(2):383-92. PubMed ID: 18716065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human thioredoxin-1 ameliorates experimental murine colitis in association with suppressed macrophage inhibitory factor production.
    Tamaki H; Nakamura H; Nishio A; Nakase H; Ueno S; Uza N; Kido M; Inoue S; Mikami S; Asada M; Kiriya K; Kitamura H; Ohashi S; Fukui T; Kawasaki K; Matsuura M; Ishii Y; Okazaki K; Yodoi J; Chiba T
    Gastroenterology; 2006 Oct; 131(4):1110-21. PubMed ID: 17030181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dietary rutin, but not its aglycone quercetin, ameliorates dextran sulfate sodium-induced experimental colitis in mice: attenuation of pro-inflammatory gene expression.
    Kwon KH; Murakami A; Tanaka T; Ohigashi H
    Biochem Pharmacol; 2005 Feb; 69(3):395-406. PubMed ID: 15652231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The simultaneous blockade of chemokine receptors CCR2, CCR5 and CXCR3 by a non-peptide chemokine receptor antagonist protects mice from dextran sodium sulfate-mediated colitis.
    Tokuyama H; Ueha S; Kurachi M; Matsushima K; Moriyasu F; Blumberg RS; Kakimi K
    Int Immunol; 2005 Aug; 17(8):1023-34. PubMed ID: 16000328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aggravation of intestinal inflammation by depletion/deficiency of gammadelta T cells in different types of IBD animal models.
    Kühl AA; Pawlowski NN; Grollich K; Loddenkemper C; Zeitz M; Hoffmann JC
    J Leukoc Biol; 2007 Jan; 81(1):168-75. PubMed ID: 17041003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-1beta targets interleukin-6 in progressing dextran sulfate sodium-induced experimental colitis.
    Kwon KH; Murakami A; Hayashi R; Ohigashi H
    Biochem Biophys Res Commun; 2005 Nov; 337(2):647-54. PubMed ID: 16202978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rosuvastatin, a new HMG-CoA reductase inhibitor, reduces the colonic inflammatory response in dextran sulfate sodium-induced colitis in mice.
    Naito Y; Katada K; Takagi T; Tsuboi H; Isozaki Y; Handa O; Kokura S; Yoshida N; Ichikawa H; Yoshikawa T
    Int J Mol Med; 2006 Jun; 17(6):997-1004. PubMed ID: 16685407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of the complement and contact systems in the dextran sulfate sodium-induced colitis model: the effect of C1 inhibitor in inflammatory bowel disease.
    Lu F; Fernandes SM; Davis AE
    Am J Physiol Gastrointest Liver Physiol; 2010 Jun; 298(6):G878-83. PubMed ID: 20338925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Orally administered lactoperoxidase ameliorates dextran sulfate sodium-induced colitis in mice by up-regulating colonic interleukin-10 and maintaining peripheral regulatory T cells.
    Shin K; Horigome A; Yamauchi K; Yaeshima T; Iwatsuki K
    Int Immunopharmacol; 2009 Nov; 9(12):1387-93. PubMed ID: 19723594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The absence of functional PI3Kgamma prevents leukocyte recruitment and ameliorates DSS-induced colitis in mice.
    van Dop WA; Marengo S; te Velde AA; Ciraolo E; Franco I; ten Kate FJ; Boeckxstaens GE; Hardwick JC; Hommes DW; Hirsch E; van den Brink GR
    Immunol Lett; 2010 Jun; 131(1):33-9. PubMed ID: 20347874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biodegradable microspheres targeting mucosal immune-regulating cells: new approach for treatment of inflammatory bowel disease.
    Nakase H; Okazaki K; Tabata Y; Chiba T
    J Gastroenterol; 2003 Mar; 38 Suppl 15():59-62. PubMed ID: 12698874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dextran sulphate sodium induces acute colitis and alters hepatic function in hamsters.
    Karlsson A; Jägervall A; Pettersson M; Andersson AK; Gillberg PG; Melgar S
    Int Immunopharmacol; 2008 Jan; 8(1):20-7. PubMed ID: 18068096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of adiponectin on murine colitis induced by dextran sulfate sodium.
    Nishihara T; Matsuda M; Araki H; Oshima K; Kihara S; Funahashi T; Shimomura I
    Gastroenterology; 2006 Sep; 131(3):853-61. PubMed ID: 16952554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of mice with dextran sulfate sodium-induced colitis with human interleukin 10 secreted by transformed Bifidobacterium longum.
    Yao J; Wang JY; Lai MG; Li YX; Zhu HM; Shi RY; Mo J; Xun AY; Jia CH; Feng JL; Wang LS; Zeng WS; Liu L
    Mol Pharm; 2011 Apr; 8(2):488-97. PubMed ID: 21271712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. VPAC1 (vasoactive intestinal peptide (VIP) receptor type 1) G protein-coupled receptor mediation of VIP enhancement of murine experimental colitis.
    Yadav M; Huang MC; Goetzl EJ
    Cell Immunol; 2011; 267(2):124-32. PubMed ID: 21295288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. R-spondin1, a novel intestinotrophic mitogen, ameliorates experimental colitis in mice.
    Zhao J; de Vera J; Narushima S; Beck EX; Palencia S; Shinkawa P; Kim KA; Liu Y; Levy MD; Berg DJ; Abo A; Funk WD
    Gastroenterology; 2007 Apr; 132(4):1331-43. PubMed ID: 17408649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The interleukin-1 beta-converting enzyme inhibitor pralnacasan reduces dextran sulfate sodium-induced murine colitis and T helper 1 T-cell activation.
    Loher F; Bauer C; Landauer N; Schmall K; Siegmund B; Lehr HA; Dauer M; Schoenharting M; Endres S; Eigler A
    J Pharmacol Exp Ther; 2004 Feb; 308(2):583-90. PubMed ID: 14610233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of gut inflammation and th17 cell response by interleukin-21.
    Fina D; Sarra M; Fantini MC; Rizzo A; Caruso R; Caprioli F; Stolfi C; Cardolini I; Dottori M; Boirivant M; Pallone F; Macdonald TT; Monteleone G
    Gastroenterology; 2008 Apr; 134(4):1038-48. PubMed ID: 18395085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of Foxp3-expressing regulatory T cells expanded with CD28 superagonist antibody in DSS-induced mice colitis.
    Chen J; Xie L; Toyama S; Hünig T; Takahara S; Li XK; Zhong L
    Int Immunopharmacol; 2011 May; 11(5):610-7. PubMed ID: 21163250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased colonic apelin production in rodents with experimental colitis and in humans with IBD.
    Han S; Wang G; Qiu S; de la Motte C; Wang HQ; Gomez G; Englander EW; Greeley GH
    Regul Pept; 2007 Aug; 142(3):131-7. PubMed ID: 17391779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 44.